171 related articles for article (PubMed ID: 19397399)
1. The association of HIV infection with left ventricular mass/hypertrophy.
Mansoor A; Golub ET; Dehovitz J; Anastos K; Kaplan RC; Lazar JM
AIDS Res Hum Retroviruses; 2009 May; 25(5):475-81. PubMed ID: 19397399
[TBL] [Abstract][Full Text] [Related]
2. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy in African children infected with HIV/AIDS: a case-control study.
Arodiwe IO; Eke CB; Arodiwe EB
Pan Afr Med J; 2023; 45():110. PubMed ID: 37719061
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Pombo M; Olalla J; Del Arco A; De La Torre J; Urdiales D; Aguilar A; Prada JL; García-Alegría J; Ruiz-Mateas F
Eur J Intern Med; 2013 Sep; 24(6):558-61. PubMed ID: 23664642
[TBL] [Abstract][Full Text] [Related]
5. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
[TBL] [Abstract][Full Text] [Related]
6. Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: data from the PAMELA population.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G
Am J Hypertens; 2014 Aug; 27(8):1079-86. PubMed ID: 24610896
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
8. What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy?
Al-Daydamony MM; El-Tahlawi M
Echocardiography; 2016 Sep; 33(9):1284-9. PubMed ID: 27109543
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study.
Conrady AO; Rudomanov OG; Zaharov DV; Krutikov AN; Vahrameeva NV; Yakovleva OI; Alexeeva NP; Shlyakhto EV
Blood Press; 2004; 13(2):101-9. PubMed ID: 15182113
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort.
Okeke NL; Alenezi F; Bloomfield GS; Dunning A; Clement ME; Shah SH; Naggie S; Velazquez EJ
J Card Fail; 2018 Aug; 24(8):496-503. PubMed ID: 29964194
[TBL] [Abstract][Full Text] [Related]
11. The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study.
Alonderis A; Raskauskiene N; Gelziniene V; Mickuviene N; Brozaitiene J
BMC Cardiovasc Disord; 2017 Sep; 17(1):250. PubMed ID: 28923022
[TBL] [Abstract][Full Text] [Related]
12. Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels.
Scuteri A; Castello L; Coluccia R; Modestino A; Nevola E; Volpe M
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):915-21. PubMed ID: 20674315
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
[TBL] [Abstract][Full Text] [Related]
14. Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients.
Chillo P; Lwakatare J; Lutale J; Gerdts E
Cardiovasc J Afr; 2012 Sep; 23(8):435-41. PubMed ID: 22447437
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus and Cardiac End-Organ Damage in Women: Findings From an Echocardiographic Study Across the United States.
Shitole SG; Lazar JM; Taub CC; Furlani AC; Konkle-Parker DJ; Dionne-Odom J; Fischl MA; Ofotokun I; Adimora AA; Topper EF; Golzar Y; Kassaye SG; Gustafson D; Anastos K; Hanna DB; Xue X; Tien PC; Kaplan RC; Kizer JR
Clin Infect Dis; 2023 Jan; 76(2):210-219. PubMed ID: 36184972
[TBL] [Abstract][Full Text] [Related]
16. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.
Wachtell K; Bella JN; Liebson PR; Gerdts E; Dahlöf B; Aalto T; Roman MJ; Papademetriou V; Ibsen H; Rokkedal J; Devereux RB
Hypertension; 2000 Jan; 35(1 Pt 1):6-12. PubMed ID: 10642267
[TBL] [Abstract][Full Text] [Related]
17. Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.
Starc TJ; Lipshultz SE; Kaplan S; Easley KA; Bricker JT; Colan SD; Lai WW; Gersony WM; Sopko G; Moodie DS; Schluchter MD
Pediatrics; 1999 Aug; 104(2):e14. PubMed ID: 10429132
[TBL] [Abstract][Full Text] [Related]
18. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic abnormalities and associated factors in a cohort of asymptomatic HIV-infected patients.
Isasti G; Pérez I; Moreno T; Cabrera F; Palacios R; Santos J
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):20-4. PubMed ID: 22891715
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
